Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review
Diabetes, Obesity and Metabolism · 2025-04 · 27 (4) · 1708-1718
DOI: 10.1111/dom.16206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 28.01.2025. Verfasst von Alice Y Y Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycemic Control, Hypoglycemic Agents, Obesity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eli Lilly and Company.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Despite the recognition by key guidelines that achieving early glycaemic control has important benefits in individuals with type 2 diabetes (T2D) and that addressing excess adiposity is one of the central components of comprehensive person‐centred T2D care, a substantial proportion of individuals with T2D do not meet their metabolic treatment goals. Prior treatment paradigms were limited by important treatment‐associated risks such as hypoglycaemia and body weight gain. Therefore, a more conservative, sequential approach to treatment was typically utilized. One potential consequence of this approach has been a missed opportunity to achieve a ‘legacy effect’, where early treatment to reach glycaemic targets is associated with enduring long‐term benefits in T2D. Additionally, while previous treatment approaches have addressed core defects in T2D, including insulin resistance and β‐cell function decline, they have been unable to address one of the underlying causal abnormalities—excess adiposity. Here, we review currently available evidence for the beneficial long‐term effects of early glycaemic control and management of body weight in people with T2D and discuss potential next steps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Eli Lilly and Company, Indianapolis, Indiana, USA.
- School of Medicine, University of Pisa, Pisa, Italy.
- Duke Department of Medicine, Duke University, Durham, North Carolina, USA.
ORCID-Profile: Alice Y Y Cheng, Stefano Del Prato, Jennifer B Green, Vivian Thuyanh Thieu, Meltem Zeytinoglu
Förderung
- Eli Lilly and Company
Zitieren
APA
Cheng, A. Y. Y., Heine, R. J., Del Prato, S., Green, J. B., Thieu, V. T., & Zeytinoglu, M. (2025). Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review. Diabetes, Obesity and Metabolism, 27(4), 1708-1718. https://doi.org/10.1111/dom.16206
Vancouver
Cheng AYY, Heine RJ, Del Prato S, Green JB, Thieu VT, Zeytinoglu M. Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review. Diabetes, Obesity and Metabolism. 2025;27(4):1708-1718. doi:10.1111/dom.16206
BibTeX
@article{Cheng2025,
author = {Cheng, Alice Y Y and Heine, Robert J and Del Prato, Stefano and Green, Jennifer B and Thieu, Vivian Thuyanh and Zeytinoglu, Meltem},
title = {Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {4},
pages = {1708--1718},
doi = {10.1111/dom.16206}
}
EUVIMED